Fig 1: Immunohistochemistry (IHC) for thymic carcinoma and type B3 thymoma with CALML5, CD5, c-kit, and GLUT-1. (a–e) A case of thymic carcinoma. (a) Hematoxylin and eosin (H&E). (b) CALML5 is expressed in the cytoplasm and the nuclei. (c) CD5 is expressed in the membrane. (d) C-kit is expressed in the membrane. (e) GLUT-1 is expressed in the membrane. (f–j) A case of type B3 thymoma. (f) H&E. The tumor cells are (g) negative for CALML5, (h) negative for CD5, (i) negative for c-kit, and (j) negative for GLUT-1. Scale bar is 100 µm. IHC, immunohistochemistry; TdT, terminal deoxynucleotidyl transferase; THYM, type B3 thymoma; TSQCC, thymic squamous cell carcinoma.
Supplier Page from DNASU for CALML5 (Homo sapiens) in pENTR223 (Gateway donor/master vector)